Vimarsana
Biggest News Aggregation in the World

Page 24 - Delivery Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Delivery Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Delivery Technologies Today - Breaking & Trending Today

FDA grants approval for OTC opioid overdose treatment - Vimarsana News

FDA grants approval for OTC opioid overdose treatment

The naloxone hydrochloride nasal spray will be made available over-the-counter, therefore not requiring a prescription, in an effort to reduce deaths from opioid abuse.

Hovione and Laxxon partner on 3D printed pharmaceuticals - Vimarsana News

Hovione and Laxxon partner on 3D printed pharmaceuticals

The two companies enter into a long-term partnership to advance 3D screen printing technologies for applications within the pharma industry.

JRS PHARMA - Vimarsana News

JRS PHARMA

JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of excipient solutions for the pharmaceutical and nutraceutical industries. Our excipients portfolio includes: high functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, gelling agents, carriers, and coatings.

Cingulate and Indegene announce agreement for lead ADHD drug - Vimarsana News

Cingulate and Indegene announce agreement for lead ADHD drug

An agreement has been reached to promote Cingulate Inc’s ‘first true entire active day medication’ designed to treat attention deficit hyperactivity disorder (ADHD).

Greenphire introduces new tech for patient communities and expands deal with Merck - Vimarsana News

Greenphire introduces new tech for patient communities and expands deal with Merck

In its bid to what it says will make participation in clinical trials easier and more sustainable, Greenphire has revealed a patient-powered registry and it has also expanded a deal with Merck.